BioLife Solutions PE Ratio 2010-2025 | BLFS
Current and historical p/e ratio for BioLife Solutions (BLFS) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. BioLife Solutions PE ratio as of July 03, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| BioLife Solutions PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-03 | 22.84 | 0.00 | |
| 2025-03-31 | 22.84 | $-0.29 | 0.00 |
| 2024-12-31 | 25.96 | $-0.50 | 0.00 |
| 2024-09-30 | 25.04 | $-1.06 | 0.00 |
| 2024-06-30 | 21.43 | $-1.69 | 0.00 |
| 2024-03-31 | 18.55 | $-1.42 | 0.00 |
| 2023-12-31 | 16.25 | $-1.52 | 0.00 |
| 2023-09-30 | 13.81 | $-2.37 | 0.00 |
| 2023-06-30 | 22.10 | $-1.93 | 0.00 |
| 2023-03-31 | 21.75 | $-3.41 | 0.00 |
| 2022-12-31 | 18.20 | $-3.26 | 0.00 |
| 2022-09-30 | 22.75 | $-2.48 | 0.00 |
| 2022-06-30 | 13.81 | $-2.25 | 0.00 |
| 2022-03-31 | 22.73 | $-0.35 | 0.00 |
| 2021-12-31 | 37.27 | $-0.21 | 0.00 |
| 2021-09-30 | 42.32 | $0.10 | 423.20 |
| 2021-06-30 | 44.51 | $0.06 | 741.83 |
| 2021-03-31 | 36.00 | $-0.83 | 0.00 |
| 2020-12-31 | 39.89 | $-0.81 | 0.00 |
| 2020-09-30 | 28.94 | $-0.73 | 0.00 |
| 2020-06-30 | 16.35 | $-0.32 | 0.00 |
| 2020-03-31 | 9.50 | $0.41 | 23.17 |
| 2019-12-31 | 16.18 | $0.44 | 36.77 |
| 2019-09-30 | 16.63 | $0.46 | 36.14 |
| 2019-06-30 | 16.95 | $0.14 | 121.07 |
| 2019-03-31 | 17.89 | $0.16 | 111.81 |
| 2018-12-31 | 12.03 | $0.13 | 92.54 |
| 2018-09-30 | 17.50 | $0.04 | 437.50 |
| 2018-06-30 | 11.41 | $-0.04 | 0.00 |
| 2018-03-31 | 5.13 | $-0.15 | 0.00 |
| 2017-12-31 | 6.00 | $-0.21 | 0.00 |
| 2017-09-30 | 5.71 | $-0.42 | 0.00 |
| 2017-06-30 | 2.39 | $-0.47 | 0.00 |
| 2017-03-31 | 2.09 | $-0.52 | 0.00 |
| 2016-12-31 | 1.61 | $-0.55 | 0.00 |
| 2016-09-30 | 1.84 | $-0.38 | 0.00 |
| 2016-06-30 | 1.60 | $-0.39 | 0.00 |
| 2016-03-31 | 1.83 | $-0.36 | 0.00 |
| 2015-12-31 | 2.17 | $-0.35 | 0.00 |
| 2015-09-30 | 2.11 | $-0.34 | 0.00 |
| 2015-06-30 | 1.95 | $-0.32 | 0.00 |
| 2015-03-31 | 1.61 | $-0.31 | 0.00 |
| 2014-12-31 | 1.64 | $-0.32 | 0.00 |
| 2014-09-30 | 2.10 | $-0.34 | 0.00 |
| 2014-06-30 | 2.28 | $-0.27 | 0.00 |
| 2014-03-31 | 3.69 | $-0.20 | 0.00 |
| 2013-12-31 | 8.40 | $-0.10 | 0.00 |
| 2013-09-30 | 11.13 | $-0.14 | 0.00 |
| 2013-06-30 | 5.04 | $-0.28 | 0.00 |
| 2013-03-31 | 4.06 | $-0.42 | 0.00 |
| 2012-12-31 | 4.76 | $-0.42 | 0.00 |
| 2012-09-30 | 1.82 | $-0.42 | 0.00 |
| 2012-06-30 | 1.26 | $-0.42 | 0.00 |
| 2012-03-31 | 1.40 | $-0.42 | 0.00 |
| 2011-12-31 | 0.70 | $-0.56 | 0.00 |
| 2011-09-30 | 1.12 | $-0.56 | 0.00 |
| 2011-06-30 | 1.12 | $-0.56 | 0.00 |
| 2011-03-31 | 1.12 | $-0.56 | 0.00 |
| 2010-12-31 | 0.77 | $-0.56 | 0.00 |
| 2010-09-30 | 1.19 | $-0.56 | 0.00 |
| 2010-06-30 | 1.33 | $-0.56 | 0.00 |
| 2010-03-31 | 1.41 | $-0.56 | 0.00 |
| 2009-12-31 | 1.54 | $-0.56 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.085B | $0.082B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.98 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |